Back to Search

MARCELA PADILLA, MS., CCC-SLP

MS., CCC-SLP

Speech-Language Pathologist

NPI: 1174768030Individual

Specialties, Licenses & Credentials

Speech-Language PathologistPrimary

Speech-Language Pathologist

Code: 235Z00000X

106798(TX)

Clinical Trials (1)

1
Linked Trials
0
Recruiting
0
With Results

The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19

NCT04619680COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Research & Publications (1)

Early nintedanib deployment in COVID-19 interstitial lung disease (ENDCOV-I): study protocol of a randomised, double-blind, placebo-controlled trial.
PMID 40216412·BMJ Open Respir Res·2025
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
2026 WIRT RD, SUITE 103B
HOUSTON, TX 77055

Quick Facts

NPI
1174768030
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
1
Locations
1
Clinical Trials
1
Publications
1

Are you this provider?

Claim Your Profile